DBCO-PEG3-VC-Exatecan
Product Specifications
CAS Number
2754384-70-6
Target
Drug-Linker Conjugates for ADC, Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related, DNA Damage/DNA Repair
Bioactivity
DBCO-PEG3-VC-Exatecan (compound 25) is a Drug-Linker Conjugate for ADC (ADC Drug-Linker Conjugate), consisting of the ADC linker (DBCO-PEG3-VC) coupled with the DNA topoisomerase I (topoisomeraseI) inhibitor Exatecan. This conjugate is utilized in the development of antibody-drug conjugates for targeted cancer therapy.
Smiles
N(C(OCC1=CC=C(NC([C@@H](NC([C@@H](NC(CCOCCOCCOCCNC(CCC(=O)N2C=3C(C#CC=4C(C2)=CC=CC4)=CC=CC3)=O)=O)[C@@H](C)C)=O)CCCNC(N)=O)=O)C=C1)=O)[C@@H]5C6=C7C(C=8N(C7)C(=O)C9=C(C8)[C@](CC)(O)C(=O)OC9)=NC=%10C6=C(CC5)C(C)=C(F)C%10
Molecular Formula
C71H79FN10O15
Molecular Weight
1331.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
337267 100 µL
Tissue factor pathway Inhibitor (lipoprotein-associated coagulation Inhibitor)
Sign In for Pricing
View Details 
134629-HRP 100 µL
TPA (Tissue-type Plasminogen Activator, t-plasminogen Activator, t-PA, tPA, Alteplase, INN=Reteplase, Tissue-type Plasminogen Activator Chain A, Tissue-type Plasminogen Activator Chain B, PLAT) (HRP)
Sign In for Pricing
View Details